Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001583648-22-000057
Filing Date
2022-07-06
Accepted
2022-07-06 17:26:00
Documents
18
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A pirs-20211231.htm   iXBRL 10-K/A 253883
2 EX-23.1 pirs12312021ex23110-ka.htm EX-23.1 8504
3 EX-31.1 pirs12312021ex31110-ka.htm EX-31.1 8037
4 EX-31.2 pirs12312021ex31210-ka.htm EX-31.2 8046
5 EX-32.1 pirs12312021ex32110-ka.htm EX-32.1 4403
6 EX-32.2 pirs12312021ex32210-ka.htm EX-32.2 4348
  Complete submission text file 0001583648-22-000057.txt   539338

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20211231.xsd EX-101.SCH 2523
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20211231_lab.xml EX-101.LAB 41671
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20211231_pre.xml EX-101.PRE 22172
12 EXTRACTED XBRL INSTANCE DOCUMENT pirs-20211231_htm.xml XML 20144
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37471 | Film No.: 221069791
SIC: 2834 Pharmaceutical Preparations